The FDA cited a Dallas home infusion therapy pharmacy for failure to maintain sterile conditions for drugmaking after inspectors found dead insects in a cleanroom and in refrigerators used to…

A Chinese maker of pain-relief balms and ointments falsified results of tests on its products and deflected FDA inspectors seeking to examine its laboratory, the FDA said in a warning…

A federal judge ruled Purdue Pharma must face most of the claims in a lawsuit filed against the drugmaker by a Washington city earlier this year. Source: Drug Industry Daily

The PTO’s Patent Trial and Appeals Board invalidated Aventis Pharma’s patent for the chemotherapy drug Jevtana (cabazitaxel), following a challenge from Mylan. Source: Drug Industry Daily

For the first time, the FDA is publishing a list of the drugs manufactured by registered outsourcing facilities. Source: Drug Industry Daily

PhRMA now supports limiting opioid prescriptions for acute pain to a seven-day supply — down from the traditional 30 — saying excess pills can end up falling into the wrong…